B. M. (2017). Candidalysin drives epithelial signaling, neutrophil recruitment, and immunopathology at the vaginal mucosa. Infection and Immunity. https://doi.ABSTRACT 31 32 Unlike other forms of candidiasis, vulvovaginal candidiasis, caused primarily by 33 the fungal pathogen Candida albicans, is a disease of immunocompetent and otherwise 34 healthy women. Despite its prevalence, the fungal factors responsible for initiating 35 symptomatic infection remain poorly understood. One of the hallmarks of vaginal 36 candidiasis is the robust recruitment of neutrophils to the site of infection, which 37 seemingly do not clear the fungus, but rather exacerbate disease symptomatology. 38
INTRODUCTION 59
Vulvovaginal candidiasis (VVC), caused primarily by the polymorphic fungal 60 pathogen Candida albicans, remains a serious worldwide health concern leading to 61 significant quality of life issues for immunocompetent women (1) . Symptomatic VVC is 62 manifested by itching, burning, and pain sensation at the vaginal and vulvar tissue, 63 often accompanied by odorless vaginal discharge (2). Globally, VVC is estimated to be 64 the most prevalent human fungal infection, with over 75% of women experiencing at 65 least one episode in their lifetime and 5-8% suffering from idiopathic recurrent infection 66
(3). In recent years, VVC has been described as an immunopathology, in which the host 67 neutrophil and associated cytokine response actually exacerbates disease symptoms, 68 yet fails to adequately control the fungus (4-7). While much effort has been placed on 69 defining host immunological mechanisms contributing to VVC protection, the fungal 70 virulence factors that dictate conversion from asymptomatic colonization to fulminant 71 infection remain poorly understood. 72
Using model systems, several laboratories have collectively begun to unravel this 73 complex host-pathogen interaction. Studies revealed that vaginal (as well as oral) 74 epithelial cells can discriminate between colonizing yeast and invasive hyphae by 75 activation of the MAPK/c-Fos/MKP1 pathway and this "sensing" is concomitant with 76 4 cellular damage (8) (9) (10) . This was largely recapitulated in the murine model of VVC, 77
where hypha-deficient strains of C. albicans (e.g. efg1Δ/Δ, efg1Δ/Δ/cph1Δ/Δ, NRG1 78 overexpression) colonized equally well or better than wild type strains, yet failed to 79 induce hallmark immunopathology (e.g. PMN/neutrophil attraction, S100A8 production, 80 IL-1β release) or mucosal damage (lactate dehydrogenase (LDH) release). It was fairly 81 unsurprising that fungal burden alone was not sufficient for symptomatic infection, as 82 the vaginal mucosa is often colonized by C. albicans without clinical presentation of 83 disease. Similarly, a live challenge study in women volunteers demonstrated that fungal 84 burden was not solely sufficient to explain VVC susceptibility, as women that were 85 highly colonized did not always develop symptoms and vice versa (4). Therefore, these 86 collective findings suggest that the yeast-to-hypha transition itself or downstream 87 hypha-associated effectors are likely required for tissue damage and subsequent 88 immunopathological inflammation at the vaginal mucosa. However, the precise fungal 89 factors and mechanisms that contribute to neutrophil recruitment, induction of 90 immunopathology, and mucosal damage remained elusive. 91 6 ( Fig. 1) . Comparatively, few genes were regulated in response to PBS-sham treatment 123 at the same time points ( Fig. S1 ). At the intermediate stage of infection (6 h post-124 infection), the majority of differentially expressed genes were up-regulated ( Fig 1A) , with 125 7 (3.8-fold), CXCL1 (19-fold), CXCL2 (26-fold), GM-CSF (10-fold), and prostaglandin 146 synthase PTGS2 (7.3-fold), many of which play critical roles in recruiting inflammatory 147 cells (particularly neutrophils) to the site of infection. Similar to previous findings, there 148 was clear induction of genes associated with MAPK activity: MAP3K2 (6.8-fold), 149 MAP2K3 (4-fold), MAP3K9 (4-fold), MAP4K4 (2.7-fold). Additionally, C. albicans 150 infection led to epithelial induction of c-FOS (32-fold) and c-JUN (17.7-fold), which 151 encode members of two families that form the heterodimeric transcription factor AP1, a 152 major effector of MAPK activation. The dual specificity phosphatase 1 (DUSP1) gene, 153 encoding a regulator of MAPK signaling, was also elevated (6.7-fold) in response to 154
C. albicans. 155
A number of genes involved in tissue repair, wound healing, or dampening of 156 active inflammation were also up-regulated during C. albicans infection, including the 157 genes coding for IL-24 (2.3-fold) and IL-1RN (4-fold) (16, 17). Interestingly, a number of 158 other related genes were also induced, including genes coding for HBEGF (heparin 159 binding EGF-like growth factor, 39.5-fold) and EREG (epiregulin, 6-fold) that are 160 members of the epidermal growth factors (EGFs). They exert their function by binding to 161 their cognate receptors EGFR or v-erb-b2 oncogene homolog (ERBB) to induce cellular 162 proliferation and healing of skin and epidermal tissues (18, 19) . damage responses. Indeed, there was a dose-dependent release of lactate 170 dehydrogenase (LDH) when Candidalysin was applied to A431 cells (Fig. 3A) . 171
Significant levels of cellular damage were observed with doses above 15 μM as 172 compared to treatment with the vehicle control. 173
Vaginal epithelial cells respond to C. albicans hyphae by activating the p38-174 MAPK and ERK1/2-MAPK signalling pathways, resulting in the regulated secretion of 175 proinflammatory cytokines (8) . To assess whether Candidalysin is capable of activating 176 these pathways, epithelial cells were exposed to Candidalysin in vitro, and c-Fos 177 production/MKP1 phosphorylation was assessed by Western blotting (Fig. 3B ). The c-178 phenotype, levels of the damage biomarker LDH were significantly reduced with these 203 same mutants as compared to infection with WT or ece1Δ/Δ+ECE1 re-integrant ( Fig.  204 4E,F). Given our previous data using hypha deficient strains, a morphogenesis defect 205 may account for this phenotype (6). However, ece1Δ/Δ and ece1Δ/Δ+ECE1 Δ184-279 206 strains robustly formed hyphae at the vaginal mucosa, as did WT and ece1Δ/Δ+ECE1 207 strains ( Fig. 4G , green arrows). Thus, these results demonstrate that Candidalysin is 208 required for vaginal immunopathogenesis in vivo and that hypha formation alone is 209 insufficient to elicit hallmark immunopathology. We also sought to determine if two inflammatory markers previously identified as 230 associated with VVC immunopathology were regulated in a Candidalysin-dependent 231 manner. Expression of the gene coding for S100a8, a calcium-binding protein with 232 important functions in antifungal defense and danger responses and strongly induced 233 intravaginally inoculated with C. albicans was tightly correlated to disease 253 symptomatology (e.g. vaginal itching, burning, discomfort) (4). Activation of innate 254 immune signaling results in the recruitment of neutrophils to the vaginal mucosa and 255 experimental evidence suggests that these cells then amplify the inflammatory cascade, 256 seemingly without reducing fungal burden (22, 25) . The in vitro and in vivo data 257 presented in this study identify Candidalysin as the crucial virulence factor that drives using targeted multiplex cytokine assays to determine host response to vaginal infection 264 (8) . Unsurprisingly, many of the genes uncovered by RNA-Seq as differentially 265 regulated during murine vaginitis were not found in our human microarray datasets (26). 266
The first explanation of this is that the human response (microarray data) is not strictly 267 homologous with the murine response. However, given the similarity and linkage of 268 immunopathology with neutrophil influx to the vaginal lumen in both human and murine 269 vaginal infections, this explanation seems less likely. A more plausible explanation is 270 that the microarray data presented here provide an epithelial-specific response that is 271 independent of hormonal modulation and the presence of other cell types. Murine RNA-272
Seq data were derived from whole vaginal tissue, thus hematopoetic and stromal 273 compartments were similarly represented (26). While each strategy offers its own 274 unique strengths and weaknesses, direct comparison between datasets must be made 275 with caution. However, despite these methodological differences, there was relatively 276 strong conservation between pro-inflammatory responses in both datasets, including 277 eicosanoid signaling (PLA2GB4, PTGS2), S100 alarmin expression, and strong CXCL2 278 experimental VVC, suggesting that mucosal damage still occurs in the absence of 360 robust classical immunopathology (6). Moreover, PMN recruitment in humans is highly 361 associated with disease onset, but has not been extensively evaluated as a requirement 362 or worsening criterion for immunopathology. Therefore, it is arguable that VVC may be 363 better categorized in class 5 of the DRF, by which the pathogen causes damage across 364 the spectrum of immune responses but damage may be enhanced by strong immune 365
responses. 366
In summary, this study demonstrates that Candidalysin is critical for the induction 367 of immunopathological signaling at the vaginal mucosa, and that these responses are 368 largely conserved at both human and murine epithelial surfaces. Furthermore, our 369 findings decouple hypha formation per se from disease symptomatology and clearly link 370 vaginitis immunopathogenesis with Candidalysin production and its capacity to directly 371 damage the vaginal mucosa. In light of these findings, studies designed to determine 372 Table S2 . using the A431 cell line were purchased from SkinEthic Laboratories (France) and used 398 as previously described (8) . RNA was isolated from three independent RVE infected 399 with C. albicans SC5314 for 6 and 24 h or an equal volume of PBS using the GenElute 400 total mammalian RNA miniprep kit (Sigma, UK) and trace genomic DNA removed using 401 the Turbo DNase-free kit (Ambion, UK). For microarray analysis, RNA was amplified 402 
